NEW YORK, May 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Molecular Diagnostics Market 2012-2016
TechNavio's analysts forecast the Global Molecular Diagnostics market to grow at a CAGR of 11.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing investments in genomics and proteomics research. The Global Molecular Diagnostics market has also been witnessing a growth in the diagnostics segment. However, the compliance with regulatory requirements could pose a challenge to the growth of this market.
TechNavio's report, the Global Molecular Diagnostics Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC regions; it also covers the market segmentation based on product types, based on application, and based on technology and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Abbott Laboratories, Becton, Dickinson and Co., QIAGEN N.V., and Roche Holding Ltd.
Other vendors mentioned in the report are Affymetrix Inc., Agilent Technologies Inc., Alere Inc., AmniSure International LLC, Anadys Pharmaceuticals Inc., Bayer HealthCare AG, Biocartis SA, bioMerieux SA, Bio-Rad Laboratories Inc., Biotest AG, Carmel Pharma AB, Celera Diagnostics LLC, Cellestis Ltd., Cepheid Inc., Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE Healthcare Ltd., Genomic Health Inc., Gen-Probe Inc., Illumina Inc., Instrumentation Laboratory Co., IRIS International Inc., Janssen Biotech Inc., KIESTRA Lab Automation BV, Life Technologies Corp., Luminex Corp., Merck and Co. Inc., mtm laboratories AG, Nanosphere Inc., Novartis AG, PerkinElmer Inc., Pharmacyclics Inc., PVT Probenverteiltechnik GmbH, Quest Diagnostics Inc., Quidel Corp., Safety Syringes Inc., SANYO North America Corp., Siemens Healthcare, Sirigen Group Limited, St. Jude Medical Inc., Sysmex Corp., and Thermo Fisher Scientific Inc.
Key questions answered in this report:
What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
Table of Contents
1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
4.1.1. Market Research Process
4.1.2. Research Design
4.1.3. Research Methodology
5. Scope of the Report
Market Overview
Product Offerings
6. Market Landscape
6.1. Market Size and Forecast
6.2. Market Segmentation Based on Product Type
6.3. Market Segmentation Based on Application
6.4. Market Segmentation Based on Technology
6.5. Five Force Analysis
7. Geographical Segmentation
8. Vendor Landscape
9. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Key Vendor Analysis
15.1. Abbott Laboratories
15.1.1. Business Overview
15.1.2. Key Information
15.1.3. SWOT Analysis
15.2. Becton, Dickinson and Co.
15.2.1. Business Overview
15.2.2. Key Information
15.2.3. SWOT Analysis
15.3. QIAGEN N.V.
15.3.1. Business Overview
15.3.2. Key Information
15.3.3. SWOT Analysis
15.4. Roche Holding Ltd.
15.4.1. Business Overview
15.4.2. Key Information
15.4.3. SWOT Analysis
16. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Global Molecular Diagnostics Market 2012-2016 (US$ billion)
Exhibit 3: Global Molecular Diagnostics Market Segmentation
Exhibit 4: Global Molecular Diagnostics Market Segmentation Based on Application
Exhibit 5: Global Molecular Diagnostics Market Segmentation Based on Application 2012
Exhibit 6: Global Molecular Diagnostics Market Segmentation Based on Technology
Exhibit 7: Global Molecular Diagnostics Market Segmentation Based on Technology 2012
Exhibit 8: Global Molecular Diagnostics Market by Geographical Segmentation 2012
Exhibit 9: Global Molecular Diagnostics Market by Vendor Segmentation 2012
Exhibit 10: Key Mergers and Acquisitions in the Global Molecular Diagnostics Market
Exhibit 11: Business Segmentation of Abbott Laboratories
Exhibit 12: Business Segmentation of Becton, Dickinson and Co.
Exhibit 13: Business Segmentation of QIAGEN N.V.
Exhibit 14: Business Segmentation of Roche Holding Ltd.
Companies Mentioned
Abbott Laboratories, Becton, Dickinson and Co., QIAGEN N.V., Roche Holding Ltd., Affymetrix Inc., Agilent Technologies Inc., Alere Inc., AmniSure International LLC, Anadys Pharmaceuticals Inc., Bayer HealthCare AG, Biocartis SA, bioMerieux SA, Bio-Rad Laboratories Inc., Biotest AG, Carmel Pharma AB, Celera Diagnostics LLC, Cellestis Ltd., Cepheid Inc., Cytometers Inc., Danaher Corp., Diagenode SA, Eli Lilly and Co., Eurogentec S.A., Evotec AG, GE Healthcare Ltd., Genomic Health Inc., Gen-Probe Inc., Illumina Inc., Instrumentation Laboratory Co., IRIS International Inc., Janssen Biotech Inc., KIESTRA Lab Automation BV, Life Technologies Corp., Luminex Corp., Merck & Co. Inc., mtm laboratories AG, Nanosphere Inc., Novartis AG, PerkinElmer Inc., Pharmacyclics Inc., PVT Probenverteiltechnik GmbH, Quest Diagnostics Inc., Quidel Corp., Safety Syringes Inc., SANYO North America Corp., Siemens Healthcare, Sirigen Group Limited, St. Jude Medical Inc., Sysmex Corp., and Thermo Fisher Scientific Inc.
To order this report:
In_Vitro_Diagnostic Industry: Global Molecular Diagnostics Market 2012-2016
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article